The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Serotonin Receptors – From Molecular Biology to Clinical Applications
Open accessAbstract
Serotonin (5-hydroxytryptamine) is an ubiquitary monoamine acting as one of the neurotransmitters at synapses of nerve cells. Serotonin acts through several receptor types and subtypes. The profusion of 5-HT receptors should eventually allow a better understanding of the different and complex processes in which serotonin is involved. Its role is expected in the etiology of several diseases, including depression, schizophrenia, anxiety and panic disorders, migraine, hypertension, pulmonary hypertension, eating disorders, vomiting and irritable bowel syndromes. In the past 20 years, seven distinct families of 5-HT receptors have been identified and various subpopulations have been described for several of them. Increasing number of 5-HT receptors has made it difficult to unravel the role of 5-HT receptor subpopulations due to the lack of suitable selective agents. The present review describes the different populations and nomenclature of recently discovered 5-HT receptors and their pharmacological relevance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The expanded biology of serotonin
Berger, M., Gray, J. A., & Roth, B. L. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.042307.110802 · Cited by 2,100
Psychopharmacology: The Third Generation of Progress.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-509_2 · Cited by 2,014
Molecular, pharmacological and functional diversity of 5-HT receptors
Hoyer, D., Hannon, J. P., & Martin, G. R. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00746-8 · Cited by 1,865
Nichols, D. E., & Nichols, C. D. (2008) · Chemical Reviews · doi:10.1021/cr078224o · Cited by 895
Ruat, M., Traiffort, E., Leurs, R., Tardivel-Lacombe, J., Diaz, J., Arrang, J. M., & Schwartz, J. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8547 · Cited by 617
5-HT1A receptor agonists: recent developments and controversial issues
De Vry, J. (1995) · Psychopharmacology · doi:10.1007/bf02245588 · Cited by 455
5-HT Receptor Classification and Nomenclature: Towards a Harmonization with the Human Genome
HOYER, D., & MARTIN, G. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00036-1 · Cited by 410
Cloning, Characterization, and Chromosomal Localization of a Human 5‐HT6 Serotonin Receptor
Kohen, R., Metcalf, M. A., Khan, N., Druck, T., Huebner, K., Lachowicz, J. E., Meltzer, H. Y., Sibley, D. R., Roth, B. L., & Hamblin, M. W. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66010047.x · Cited by 377
Functional, molecular and pharmacological advances in 5-HT receptor research
HEDLUND, P., & SUTCLIFFE, J. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.07.002 · Cited by 350
Goodwin, G. M., Emsley, R., Rembry, S., Rouillon, F., & the Agomelatine Study Group (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04548 · Cited by 340
Ciranna, L. (2006) · Current Neuropharmacology · doi:10.2174/157015906776359540 · Cited by 336
Serotonin receptors in cognitive behaviors
Buhot, M.-C. (1997) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(97)80013-x · Cited by 307
Role of serotonin in the pathophysiology of the irritable bowel syndrome
Crowell, M. D. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705762 · Cited by 291
Adham, N., Kao, H. T., Schecter, L. E., Bard, J., Olsen, M., Urquhart, D., Durkin, M., Hartig, P. R., Weinshank, R. L., & Branchek, T. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.408 · Cited by 289
Dubin, A. E., Huvar, R., D'Andrea, M. R., Pyati, J., Zhu, J. Y., Joy, K. C., Wilson, S. J., Galindo, J. E., Glass, C. A., Luo, L., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.30799 · Cited by 281
The 5-HT3receptor as a therapeutic target
Thompson, A. J., & Lummis, S. C. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.4.527 · Cited by 257
Primary structure and functional characterization of a human 5-HT1D-type serotonin receptor.
Hamblin, M. W., & Metcalf, M. A. (1991) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)12918-0 · Cited by 228
The activation of 5‐HT2A receptors in prefrontal cortex enhances dopaminergic activity
Bortolozzi, A., Díaz‐Mataix, L., Scorza, M. C., Celada, P., & Artigas, F. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03485.x · Cited by 224
Nilsson, T., Longmore, J., Shaw, D., Pantev, E., Bard, J. A., Branchek, T., & Edvinsson, L. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00114-4 · Cited by 215
Feng, J., Cai, X., Zhao, J., & Yan, Z. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-17-06502.2001 · Cited by 212
Nebigil, C. G., Launay, J.-M., Hickel, P., Tournois, C., & Maroteaux, L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050282397 · Cited by 183
In vivo properties of SB 200646A, a 5‐HT2C/2Breceptor antagonist
Kennett, G. A., Wood, M. D., Glen, A., Grewal, S., Forbes, I., Gadre, A., & Blackburn, T. P. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb14808.x · Cited by 181
Bourson, A., Borroni, E., Austin, R. H., Monsma, F. J., & Sleight, A. J. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10539-9 · Cited by 181
Reynolds, G. P., Mason, S. L., Meldrum, A., De Keczer, S., Parties, H., Eglen, R. M., & Wong, E. H. F. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb13303.x · Cited by 180
Characterization of the human 5-hydroxytryptamine1B receptor.
Jin, H., Oksenberg, D., Ashkenazi, A., Peroutka, S. J., Duncan, A. M., Rozmahel, R., Yang, Y., Mengod, G., Palacios, J. M., & O'Dowd, B. F. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42612-9 · Cited by 177
Increased Fear Response to Contextual Cues in Mice Lacking the 5-HT1A Receptor
Klemenhagen, K. C., Gordon, J. A., David, D. J., Hen, R., & Gross, C. T. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300774 · Cited by 167
Cloning and functional characterization of the human 5‐HT2B serotonin receptor
Schmuck, K., Ullmer, C., Engels, P., & Lübbert, H. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80590-3 · Cited by 158
How Stress and Fluoxetine Modulate Serotonin 2C Receptor Pre-mRNA Editing
Englander, M. T., Dulawa, S. C., Bhansali, P., & Schmauss, C. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3895-04.2005 · Cited by 157
Cook, E. H., Fletcher, K. E., Wainwright, M. S., Marks, N., Yan, S., & LEVENTHAL, B. L. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63020465.x · Cited by 150
Drug-induced fibrotic valvular heart disease
Bhattacharyya, S., Schapira, A. H. V., Mikhailidis, D. P., & Davar, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60252-x · Cited by 147
Serotonergic measures in suicide brain: 5-HT1A binding sites in frontal cortex of suicide victims
Matsubara, S., Arora, R. C., & Meltzer, H. Y. (1991) · Journal of Neural Transmission · doi:10.1007/bf01244944 · Cited by 145
Grailhe, R., Grabtree, G. W., & Hen, R. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00933-5 · Cited by 130
The role of central 5‐hydroxytryptamine (5‐HT, serotonin) receptors in the control of micturition
Ramage, A. G. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706504 · Cited by 127
5‐HT2B receptors play a key role in mediating the excitatory effects of 5‐HT in human colon in vitro
Borman, R. A., Tilford, N. S., Harmer, D. W., Day, N. C., Ellis, E. S., Sheldrick, R. L. G., Carey, J. E., Coleman, R. A., & Baxter, G. S. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704571 · Cited by 124
Nelson, D. (2004) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007043482606 · Cited by 113
Pindolol Augmentation of Antidepressant Response
Artigas, F., Adell, A., & Celada, P. (2006) · Current Drug Targets · doi:10.2174/138945006775515446 · Cited by 111
Mediation by 5‐hydroxytryptamine2Breceptors of endothelium‐dependent relaxation in rat jugular vein
Ellis, E. S., Byrne, C., Murphy, O. E., Tilford, N. S., & Baxter, G. S. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb13240.x · Cited by 100
5-ht5A receptors as a therapeutic target
Thomas, D. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.12.006 · Cited by 93
Human gene S31 encodes the pharmacologically defined serotonin 5-hydroxytryptamine1E receptor.
Zgombick, J. M., Schechter, L. E., Macchi, M., Hartig, P. R., Branchek, T. A., & Weinshank, R. L. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08894-7 · Cited by 87
Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated
Kennett, G. A., Trail, B. K., & Bright, F. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00115-4 · Cited by 86
5-HT7 Receptor Antagonists as a New Class of Antidepressants
Mnie‐Filali, O., Lambás‐Señas, L., Zimmer, L., & Haddjeri, N. (2007) · Drug News & Perspectives · doi:10.1358/dnp.2007.20.10.1181354 · Cited by 71
Mialet‐Perez, J., Berque‐Bestel, I., Eftekhari, P., Gastineau, M., Giner, M., Dahmoune, Y., Donzeau‐Gouge, P., Hoebeke, J., Langlois, M., Sicsic, S., et al. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703101 · Cited by 71
5-HT1A receptor and 5-HT1B receptor knockout mice in stress and anxiety paradigms.
Groenink, L., van Bogaert, M. J. V., van der Gugten, J., Oosting, R. S., & Olivier, B. (2003) · PubMed · doi:10.1097/01.fbp.0000087737.21047.75 · Cited by 70
O‘Neill, M. F., Fernández, A. G., & Palacios, J. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02047-0 · Cited by 65
5‐HT3 Receptors: Pharmacologic and Therapeutic Aspects
Gyermek, L. (1995) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1995.tb04129.x · Cited by 64
Is migraine prophylactic activity caused by 5-HT2B or 5-HT2C receptor blockade?
Kalkman, H. O. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00546-x · Cited by 62
Doggrell, S. A. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.5.805 · Cited by 62
Adham, N., Bard, J., Zgombick, J. M., Durkin, M. M., Kucharewicz, S., Weinshank, R. L., & Branchek, T. A. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00020-8 · Cited by 61
Pasqualetti, M., Nardi, I., Ladinsky, H., Marazziti, D., & Cassano, G. B. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(96)00026-5 · Cited by 61
Shi (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000225 · Cited by 59
Effects of altered 5-ht6 expression in the rat: functional studies using antisense oligonucleotides
Sleight, A. J., Monsma, F. J., Borroni, E., Austin, R. H., & Bourson, A. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00105-2 · Cited by 56
Cutrer, F. M., Yu, X., Ayata, G., Moskowitz, M. A., & Waeber, C. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00032-5 · Cited by 53
5-HT6 receptor antagonists: prospects for the treatment of cognitive disorders including dementia.
Johnson, C. N., Ahmed, M., & Miller, N. D. (2008) · PubMed · Cited by 46
Rodd, Z. A., Gryszowka, V. E., Toalston, J. E., Oster, S. M., Ji, D., Bell, R. L., & McBride, W. J. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.112607 · Cited by 43
Pau, D., Workman, A., Kane, K., & Rankin, A. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.08.007 · Cited by 41
Knight, J. A., Smith, C., Toohey, N., Klein, M. T., & Teitler, M. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.052084 · Cited by 41
Cox, D. A., & Cohen, M. L. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24298-7 · Cited by 41
5-HT7 receptor-mediated dilatation in the middle meningeal artery of anesthetized rats
Terrón, J. A., & Martínez-García, E. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.01.019 · Cited by 38
The role of the 5-HT1D receptor as a presynaptic autoreceptor in the guinea pig
Pullar, I. A., Boot, J. R., Broadmore, R. J., Eyre, T. A., Cooper, J., Sanger, G. J., Wedley, S., & Mitchell, S. N. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.04.029 · Cited by 38
Kim, S., Shin, I., Kim, J., Youn, T., Yang, S., Hwang, M. Y., & Yoon, J. (2009) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e318184fafd · Cited by 36
Pau, D., Workman, A. J., Kane, K. A., & RANKIN, A. C. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705553 · Cited by 35
The 5-HT1A receptor: an overview of recent advances
Mestikawy, S. E., Fargin, A., Raymond, J. R., GOZLAN, H., & Hnatowich, M. R. (1991) · Neurochemical Research · doi:10.1007/bf00965820 · Cited by 33
Adham, N., Vaysse, P. J.-J., Weinshank, R. L., & Branchek, T. A. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90070-1 · Cited by 29
Storvik, M., Häkkinen, M. R., Tupala, E., & Tiihonen, J. (2008) · Alcohol and Alcoholism · doi:10.1093/alcalc/agn090 · Cited by 28
Shimron‐Abarbanell, D., Nöthen, M. M., Erdmann, J., & Propping, P. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(95)00003-b · Cited by 26
Binding of tryptamine analogs at h5-HT1E receptors: a structure–affinity investigation
Dukat, M., Smith, C., Herrick‐Davis, K., Teitler, M., & Glennon, R. A. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.03.026 · Cited by 25
Chang, C.-W., Poteet, E. C., Schetz, J. A., Gumus, Z. H., & Weinstein, H. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.049 · Cited by 25
Serotonin receptors and systems: endless diversity?
Hannon, J. P., & Hoyer, D. (2002) · Acta Biologica Szegediensis · Cited by 23
Effect of serotonin on small intestinal contractility in healthy volunteers
Hansen, M., Arif, F., Gregersen, H. N., Bruusgaard, H., & Wallin, L. (2008) · Physiological Research · doi:10.33549/physiolres.931177 · Cited by 20
Cited by
The Intestinal Microenvironment and Functional Gastrointestinal Disorders
Barbara, G., Feinle-Bisset, C., Ghoshal, U. C., Santos, J., Vanner, S. J., Vergnolle, N., Zoetendal, E. G., & Quigley, E. M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.028 · Cited by 335
Yamanaka, H., Yokoyama, C., Mizuma, H., Kurai, S., Finnema, S. J., Halldin, C., Doi, H., & Onoe, H. (2014) · Translational Psychiatry · doi:10.1038/tp.2013.112 · Cited by 84
Akyuz, E., Arulsamy, A., Aslan, F. S., Sarisözen, B., Guney, B., Hekimoglu, A., Yilmaz, B. N., Retinasamy, T., & Shaikh, M. F. (2025) · Molecular Neurobiology · doi:10.1007/s12035-024-04333-y · Cited by 69
Control of neuronal excitability by GSK-3beta: epilepsy and beyond.
Jaworski, T. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118745 · Cited by 43
Serotonin Syndrome Associated With Clozapine Withdrawal
Stevenson, E., Schembri, F., Green, D. M., & Burns, J. D. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.95 · Cited by 39
Metadata
- Authors
- PYTLIAK, M., VARGOVÁ, V., MECHÍROVÁ, V., & FELŠÖCI, M.
- Venue
- Physiological Research
- Published
- 2011-02-14
- Volume
- 60
- Issue
- 1
- Pages
- 15-25
- ISSN
- 0862-8408 (ISSN-L)
- 1802-9973
- OpenAlex
- W2140516726
- Cited by
- 318
- References
- 69
- FWCI
- 8.22
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.